
pmid: 19047432
* Young infants who have meningitis may present with nonspecific clinical manifestations. * S. pneumoniae and N. meningitidis remain the most common causes of bacterial meningitis in the infant and child, and GBS continues to be the most common neonatal pathogen. * Empiric therapy for suspected bacterial meningitis in a non-neonate includes a combination of parenteral vancomycin and either cefotaxime or ceftriaxone. * Children whose GCS scores are less than 8, show signs of shock or respiratory compromise, and have focal neurologic findings or clinical signs of elevated intracranial pressure should be admitted to a pediatric intensive care unit. * Sensorineural hearing loss occurs in 30% of children who have pneumococcal and 10% of those who have meningococcal meningitis.
Incidence, Ceftriaxone, Infant, Cefotaxime, Meningitis, Meningococcal, Anti-Bacterial Agents, Meningitis, Bacterial, Vancomycin, Humans, Drug Therapy, Combination, Meningitis, Intracranial Hypertension, Hearing Loss
Incidence, Ceftriaxone, Infant, Cefotaxime, Meningitis, Meningococcal, Anti-Bacterial Agents, Meningitis, Bacterial, Vancomycin, Humans, Drug Therapy, Combination, Meningitis, Intracranial Hypertension, Hearing Loss
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 40 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
